CYTOMED THERAPEUTICS LTD (GDTC)
SGXZ17669631 - Common Stock
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -3.06M | -4.13M | -3.13M | -2.05M | -1.94M | |||
| Depreciation Amortization | 344.93K | 381.15K | 390.00K | 330.00K | 290.00K | |||
| Change In Working Capital | 611.03K | 201.71K | 110.00K | -370.00K | 120.00K | |||
| Interest Paid | 15.76K | 46.71K | 130.00K | 120.00K | 110.00K | |||
| Taxes Paid | N/A | 2.19K | N/A | 0.00 | 0.00 | |||
| Other non cash items | -448.16K | 116.83K | 1.23M | 370.00K | 680.00K | |||
| OPERATING CASH FLOW | -2.56M | -3.43M | -1.40M | -1.71M | -850.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -951.28K | -58.30K | -470.00K | -580.00K | -270.00K | |||
| Other Investing Activity | 1.69M | -2.77M | 0.00 | -240.00K | -250.00K | |||
| INVESTING CASH FLOW | 742.96K | -2.83M | -470.00K | -820.00K | -510.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -14.30K | -340.43K | -130.00K | 290.00K | 1.49M | |||
| Stock Issued/Repurchased | 0.00 | 11.31M | 1.22M | 2.00M | 500.00K | |||
| Other Financing Activity | -15.76K | -46.71K | -130.00K | 1.88M | -110.00K | |||
| FINANCING CASH FLOW | -30.05K | 10.92M | 970.00K | 4.17M | 1.88M | |||
| Exchange Rate Effect | 70.20K | -13.41K | -30.00K | -10.00K | -10.00K | |||
| CHANGE IN CASH | -1.77M | 4.64M | -930.00K | 1.63M | 510.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -2.56M | -3.43M | -1.40M | -1.71M | -850.00K | |||
| Capital Expenditure | -951.28K | -58.30K | -470.00K | -580.00K | -270.00K | |||
| FREE CASH FLOW | -3.51M | -3.49M | -1.87M | -2.29M | -1.12M | |||
All data in SGD